SYNGENE - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 2.3
Show all parameters (20 more)
🧾 Chart Verdict
Short-term entry zones could be established between 367 ₹ (the low) and 385 ₹, utilizing support levels as potential buy triggers. An exit strategy would target resistance around 410 ₹, or a retracement of the previous rally high at approximately 435 ₹. Overall, the chart pattern is bearish with short-term risk outweighing opportunities given the momentum and near-term technical setup.
✅ Positive
The stock is trading near its recent low, providing a potential floor for buyers. Increased volume suggests some renewed interest in the shares, potentially indicating a shift in sentiment. Momentum appears to be stabilizing after a significant downtrend.
⚠️ Limitation
Despite the recent price decline and higher volume, the RSI remains relatively low (27.6), suggesting that negative momentum hasn't completely exhausted itself. The 50-day DMA is still below the 200-day DMA, indicating a longer-term bearish trend which could continue to put downward pressure on the stock’s price.
📉 Company Negative News
Recent news highlights a significant drop to a 52-week low and a deepening sell-off, suggesting broader market concerns or specific negative developments related to Syngene's performance are contributing to the decline. Univest reports reinforce this concerning price action with no immediate positive counterpoints.
🏭 Industry
The biotechnology sector (where Syngene operates) has been experiencing increased volatility recently, possibly linked to broader market anxieties and concerns around pharmaceutical company earnings. The industry PE is currently higher than Syngene’s at 37.4, suggesting relative valuation pressures within the biotech space.